These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4217757)

  • 21. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
    Kirti S; Dutta PK; Vaishnava H; Singh RB
    J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of tolbutamide and glibenclamide on intestinal glucose absorption.
    Teale JD; Love AH
    Biochem Pharmacol; 1972 Jul; 21(13):1839-48. PubMed ID: 4630399
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of sulfonylureas on lipid levels in diabetic patients].
    Sgambato S; Cristiano L; Torella R
    Rass Int Clin Ter; 1968 Apr; 48(8):455-62. PubMed ID: 5736035
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influencing of blood sugar, serum insulin level and nonesterified fatty acids during continuous feeding following orally administered sulfonylurea compounds ARDF 26 and glibenclamide].
    Zilker T; Waldthaler A; Lüders T; Ermler R; Bottermann P
    Verh Dtsch Ges Inn Med; 1974; 80():1299-302. PubMed ID: 4217979
    [No Abstract]   [Full Text] [Related]  

  • 25. Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.
    Moro C; Pillard F; de Glisezinski I; Klimcakova E; Crampes F; Thalamas C; Harant I; Marques MA; Lafontan M; Berlan M
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E505-13. PubMed ID: 18559985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A defect in lipid mobilization from adipose tissue in diphtheritic guinea pigs.
    Challoner DR; McKEE M
    J Lab Clin Med; 1973 Aug; 82(2):187-94. PubMed ID: 4737241
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dose-dependent action of insulin on carbohydrate and lipid metabolism parameters in swine blood plasma].
    Brenner KV; Gürtler H; Schmidt G
    Arch Exp Veterinarmed; 1982; 36(2):269-78. PubMed ID: 7049109
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes of blood sugar, serum insulin and free fatty acids following tolbutamide and glibenclamide in subjects of normal metabolism, pretreated with alpha and beta receptor blockaders].
    Haupt E; Cordes U; Köberich W; Beyer J; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():1072-6. PubMed ID: 5005542
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of insulin and glucagon on Intralipid-induced ketogenesis in the human].
    Keller U
    Beitr Infusionther Klin Ernahr; 1986; 13():71-82. PubMed ID: 3539088
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of hypoglycemic sulfonamides on glucagon and insulin secretion in ducks and dogs.
    Kajinuma H; Kuzuya TT; Ide T
    Diabetes; 1974 May; 23(5):412-7. PubMed ID: 4208464
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of chronic and acute treatment with sulfonylureas on plasma insulin and glucose levels in the rat.
    Codina J; Lasuncion MA; Herrera E
    Diabete Metab; 1978 Mar; 4(1):47-52. PubMed ID: 97105
    [No Abstract]   [Full Text] [Related]  

  • 32. A stimulatory effect of tolbutamide on the insulin-mediated glucose uptake in subjects with impaired glucose tolerance (IGT).
    Schulz B; Ratzmann KP; Heinke P; Besch W
    Exp Clin Endocrinol; 1983 Aug; 82(2):222-31. PubMed ID: 6354732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of the hypoglycaemic and antilipolytic effects of four antidiabetic agents administered i.v.
    Guirgis FK; Ghanem MH; Abdel-Hay MM
    Arzneimittelforschung; 1976; 26(3):435-7. PubMed ID: 134717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
    Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
    Verh Dtsch Ges Inn Med; 1971; 77():556-9. PubMed ID: 5155896
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lipid mobilization in obesity without carbohydrate intolerance. 2. Caffeine-stimulated lipolysis].
    Ratzmann KP; Riemer D; Männchen E; Paul I
    Endokrinologie; 1976; 68(3):319-26. PubMed ID: 1009910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 38. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 39. [Levels of basal insulinemia and changes of the plasmatic concentration of nonesterified fatty acids (NEFA) and of blood sugar after administration of tolbutamide in obese children].
    Iafusco F; Pierantoni G; Stoppoloni G; Pacelli V
    Pediatria (Napoli); 1967; 75(5):780-8. PubMed ID: 5603123
    [No Abstract]   [Full Text] [Related]  

  • 40. [The behavior of glucose, pyruvic acid and nonesterified fatty acids following i.v. tolbutamide loading in fatty liver].
    Teichmann W; Bchardt U
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):217-20. PubMed ID: 5732400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.